image
Coya Therapeutics, Inc. COYA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.32
-7.2 %
$ 106 M
Market Cap
-9.72
P/E
BALANCE SHEET
41.3 M ASSETS
391.48%
Growth Rates
1Year 391.48%
3Years 67.70%
5Years 0.00%
7Years 0.00%
10Years 0.00%
5.63 M LIABILITIES
-66.49%
Growth Rates
1Year -66.49%
3Years 132.60%
5Years 0.00%
7Years 0.00%
10Years 0.00%
35.6 M EQUITY
524.56%
Growth Rates
1Year 524.56%
3Years 62.52%
5Years 0.00%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Coya Therapeutics, Inc.
image
Current Assets 41.2 M
Cash & Short-Term Investments 32.6 M
Receivables 7.5 M
Other Current Assets 1.07 M
Non-Current Assets 65.9 K
Long-Term Investments 0
PP&E 65.9 K
Other Non-Current Assets 0
Current Liabilities 5.05 M
Accounts Payable 1.16 M
Short-Term Debt 0
Other Current Liabilities 3.9 M
Non-Current Liabilities 575 K
Long-Term Debt 0
Other Non-Current Liabilities 575 K

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 32.6 5.9 4.3 8.7
Short Term Investments 0 0 0 0
Receivables 7.5 0 0 1 K
Inventory 0 0 0 0
Other Current Assets 1.1 2.5 0.2 27.3 K
Total Current Assets 41.2 7.2 4.6 8.7
PP&E 65.9 K 93.3 K 0.1 0
Intangible Assets 0 0 0 0
Goodwill 0 0 0 0
Long Term Investments 0 0 0 0
Other Long Term Assets 0 1.1 87.2 K 0
Other Assets 0 0 0 0
Total Assets 41.3 8.4 4.8 8.7
LIABILITIES
Accounts Payable 1.2 1.8 0.9 0.4
Short Term Debt 0 0 0 0
Other Current Liabilities 2.2 2.0 0.3 0
Total Current Liabilities 5.1 3.8 1.1 0.4
Long Term Debt 0 13.0 0 0
Deferred Tax Income 0 0 0 0
Other Liabilities 0 0 0 0
Total Liabilities 5.6 16.8 1.1 0.4
EQUITY
Common Stock 1.44 K 259 259 259
Retained Earnings (25.9) (17.9) (5.6) (0.7)
Other Accumulative Comprehensive Income/Loss 11.2 K 0 0 0
Total Equity 35.6 (8.4) 3.6 8.3
Total Liabilities and Equity 41.3 8.4 4.8 8.7
SHARES OUTSTANDING
Common Shares Outstanding 10.2 9.9 9.7 9.7